Corporate Venture Capital

Corporate venture capital (CVC)

This is venture capital funding provided by major corporations to startup companies with a high potential for growth.

Funding is typically sourced through the capital budget of the corporation, as compared to that sourced from investors in the case of the independent venture capital fund. These corporate venture capital arms either invest in ventures that have some level of strategic synergies with their company’s business or they invest because of financial objectives.

The latter may make sense for privately held companies, but many would argue that financial returns should not be the objective of the publicly traded company. This is because, in theory, the public company investors’ interest is in the firm’s core business, and not necessarily in riskier venture investing. Should they be, they would likely be better served to invest directly through a venture capital fund or other private equity vehicles which is focused on such investments.

CVC bring administrative support, infrastructure, management and marketing expertise, and technology to the venture.

Like angel groups and venture capital funds, corporate venture capital arms invest in startups in all stages of development, from seed to the expansion, growth and mezzanine levels. Generally, their desired liquidation event is not an IPO. As indicated above, they tend more toward the acquisition of the startup.

FundingSage’s Listing of CVC Funds

Several of these CVC Funds are spotlighted on our FundingSage Startup Investor Spotlight. Learn more about potential CVC investors there!

301 Inc. (General Mills Venture Arm)

Abbvie Biotech Ventures

Airbus Ventures

Alexandria Venture Investments

Amgen Ventures

Ascension Health Ventures

Astellas Venture Management

AXA Strategic Ventures

Baidu Capital

BASF Venture Capital America, Inc.

Bertelsmann Digital Media Investments

BlueCross BlueShield Venture Partners

BMW i Ventures

Boehringer Ingelheim Ventures


Chevron Technology Ventures


Comcast Ventures

ConocoPhillips Technology Ventures

Danone Ventures

Dow Ventures

DSM Venturing B.V.

eighteen94 Capital (Kellogg’s VC Fund)

Fosun RZ Capital

GE Ventures

GM Ventures

GV (Google Ventures)

IBM Venture Capital

InMotion Ventures (England)

Intel Capital

Johnson & Johnson Development Corp

Juniper Networks Ventures

Kaiser Permanente Ventures

Kearny Venture Partners

Legend Capital

Lenovo Capital & Incubator Group

Lilly Ventures

Media Tek Ventures

Medtronic Venture Capital

Merck Global Health Innovation Fund, LLC

Merck Ventures

Merieux Developpement

M12 (Microsoft Corporation)

Mitsubishi UFJ Capital

Motorola Solutions Venture Capital

MP Healthcare Venture Management

Nike Innovation + Fuel Lab

Novartis Venture Funds (Switzerland)

Novo Ventures

NTT DoCoMo Capital



Pfizer Venture Investments

Proctor and Gamble Ventures

Qualcomm Ventures

Quintiles Transnational Corp (NovaQuest Capital Management)

Rakuten Ventures (Japan)

Robert Bosch Venture Capital

Roche Venture Fund

S.R. One, Limited (GSK)

SAIC Capital


Samsung Venture Investment

Sanofi Genzyme BioVentures

Sapphire Ventures

Shell Technology Ventures

Sony Innovation Fund

Swisscom Ventures (Cloud Innovation Lab)

Synchrony Financial

Takeda Research investment

Tate & Lyle Ventures

Telstra Ventures (Australia)

Tengelmann Ventures

Third Point Ventures

Toyota AI Ventures

T-Venture Holding

Unilever Technology Ventures

UPS Strategic Enterprise Fund

Verizon Ventures

Volvo Venture Capital

ZX Ventures (AB Inbev Venture Group) (backed by Anheuser-Busch InBev)